相关实验视频

Updated: May 30, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

慢性严重的中性高质与多焦点运动神经病变的静脉免疫球蛋白相关

Shannon Ugarte¹, Talia Gebhard^1,2, David R Cornblath²

¹Department of Medicine Division of Hematology-Oncology University of Pennsylvania Philadelphia Pennsylvania USA.

|January 28, 2025

概括

静脉注射免疫球蛋白 (IVIG) 治疗很少会导致慢性严重的中性质,即白细胞的危险下降. 这一案例凸显了长期IVIG治疗自身免疫性疾病期间监测血液样本的重要性.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
神经学神经学

背景情况:

静脉注射免疫球蛋白 (IVIG) 是对自身免疫性疾病的关键免疫调节疗法.
虽然IVIG通常是安全的,但很少引起不良反应,包括中性质衰竭 (中性粒细胞数量低).
以前的报告主要记录了与IVIG相关的轻度和短暂的中性质.

研究的目的:

报告一种罕见的IVIG诱导的慢性严重中性质衰竭病例.
描述这种情况的诊断和管理策略.
审查有关IVIG相关的中性质衰竭的现有文献.

主要方法:

一个患有多焦点运动神经病变的病人的病例报告.
对连续血液计数的分析揭示了循环性中性衰竭模式.
关于IVIG诱导的中性质的文献综述.

主要成果:

患者在开始IVIG后的几年内出现了慢性严重的中性质疏松症 (<0.5×10^3/μL).
在IVIG输液注入后24-48小时内,中性质衰竭周期性恶化.
这代表了一种罕见的慢性和严重的IVIG诱导的中性质.

结论:

IVIG可以诱导慢性严重的中性质疏松症,甚至在治疗几年后.
对长期IVIG治疗的患者来说,对中性粒细胞计数的周期性监测至关重要.
了解和管理这种罕见的不良影响对于患者的安全至关重要.

关键词:

自身免疫性疾病是一种自身免疫性疾病.IVIGIG IVIGIG 这是一个很好的例子.在IVIG引起的中性质衰竭中,IVIG引起的中性质衰竭中.慢性中性低血压症是什么静脉内注射的免疫球蛋白是一种免疫球蛋白.多焦点运动神经病变.中性变质症中性变质症中性变质症中性粒细胞中性粒细胞.

更多相关视频

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...